The Fallacy of Amyloid and Cognition in Alzheimer's Disease

Author： Lee Hyoung-gon   Zhu Xiongwei   Perry George   Smith Mark A.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.23, Iss.2, 2006-01, pp. : 179-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amyloid Forming Proteases: Therapeutic Targets for Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 8, Iss. 28, 2002-12 ,pp. : 2521-2531

Bentham Science Publishers

Access to resources Recommend Favorite

-Amyloid Disrupting Drugs: Potential in the Treatment of Alzheimer's Disease

By Soto C.  

CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. : 347-356

Adis International

Access to resources Recommend Favorite

Amyloid Associated Proteins in Alzheimer's and Prion Disease

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 3, 2005-06 ,pp. : 235-248

Bentham Science Publishers

Access to resources Recommend Favorite

&bgr;-Amyloid therapies in Alzheimer’s disease

By Jhee S.   Shiovitz T.   Crawford A.W.   Cutler N.R.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. : 593-605

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Amyloid-&bgr; Aggregation in Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 8, 2014-03 ,pp. : 1223-1243

Bentham Science Publishers

Access to resources Recommend Favorite